{"id":"NCT00401752","sponsor":"AstraZeneca","briefTitle":"Efficacy and Safety Study of Esomeprazole 20mg qd vs Ranitidine 150mg Bid in Patients With an NSAID-induced Gastric Ulcer","officialTitle":"A Multicenter, Randomized, Double-blind, Double-dummy, Parallel-group, 8 Week Comparative Efficacy and Safety Study of Esomeprazole 20 mg Every Day (qd) Versus Ranitidine 150 mg Twice a Day (Bid) in Patients With an NSAID-associated Gastric Ulcer When Daily NSAID is Continued","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-03","primaryCompletion":null,"completion":"2008-11","firstPosted":"2006-11-22","resultsPosted":"2010-07-08","lastUpdate":"2010-07-08"},"enrollment":397,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Gastric Ulcer"],"interventions":[{"type":"DRUG","name":"Esomeprazole","otherNames":[]},{"type":"DRUG","name":"Ranitidine","otherNames":[]}],"arms":[],"summary":"The purpose of this study is to assess the efficacy of esomeprazole 20 mg dosed once daily and ranitidine 150 mg dosed twice daily through 4 weeks of treatment for the healing of gastric ulcers in patients receiving daily non-steroidal anti-inflammatory drug (NSAID)therapy.","primaryOutcome":{"measure":"The Percentage of Subjects Whose Gastric Ulcer(s) (GUs) Was (Were) Healed at Week 4 After Treatment With Esomeprazole 20 mg qd and Ranitidine 150 mg Bid in Patients Receiving Daily Non-steroidal Anti-inflammatory Drug (NSAID)Therapy.","timeFrame":"4 weeks","effectByArm":[{"arm":"Esomeprazole","deltaMin":59.4,"sd":null},{"arm":"Ranitidine","deltaMin":59.5,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":2},"locations":{"siteCount":9,"countries":["China","Hong Kong"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":107},"commonTop":["Gastritis erosive","Dizziness","Gastric ulcer","Abdominal pain upper","Upper respiratory tract infection"]}}